Purpose
|
AT13148 is an oral, ATP-competitive, multi-AGC kinase inhibitor with IC50 of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively. Phase 1.
|
Characteristics
|
Target: Akt inhibitor, ROCK inhibitor,S6 Kinase inhibitor, PKA inhibitor Receptor: PKA,ROCK2,ROCK1,p70S6K,Akt1,Akt3,SGK3,RSK1,Akt2
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
97?% +
|
Formula
|
C17H16ClN3O
|
Solubility
|
200 mM in DMSO
|